---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008605"
form_type: "8-K"
ticker: "PTIX"
cik: "0001022899"
company_name: "Protagenic Therapeutics, Inc.new"
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T21:58:27.509786+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Protagenic Therapeutics appoints William Nichols as President; base salary $350k, 40% bonus target, 1% option grant

## Summary
- William (Bill) Nichols, Jr., age 51, appointed President effective Feb 3, 2026.
- Prior senior commercial leadership roles at bluebird bio, Dova Pharmaceuticals, and Bristol-Myers Squibb.
- Annual base salary $350,000; eligible for annual target bonus of 40% of base salary.
- Employment agreement includes option grant equal to ~1.0% of fully diluted share count.
- No family relationships or transactions requiring Item 404(a) disclosure.

## SEC filing metadata
- accession: 0001493152-26-008605
- form_type: 8-K
- ticker: PTIX
- cik: 0001022899
- company_name: Protagenic Therapeutics, Inc.new
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/0001493152-26-008605-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008605
- JSON: https://secwatch.observer/filing/0001493152-26-008605.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008605.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.